Biocon gets MHRA UK nod for weight management injection Liraglutide Ruchika Sharma1 April 2024 2:22 PM ISTBangalore: Biocon Limited, through its European partner, Zentiva, has received approval from the Medicines and Healthcare Products Regulatory...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Biocon CFO Indranil Sen Resigns Divyani Paul16 March 2024 2:46 PM ISTBangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post...
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara Ruchika Sharma1 March 2024 3:30 PM ISTStelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...
Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations Ruchika Sharma1 March 2024 12:01 PM ISTBangalore: Biocon has recently announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483s with 4 observations at...
Biocon receives over Rs 3 crore penalty over GST related issues Ruchika Sharma24 Feb 2024 4:30 PM ISTNew Delhi: Biocon Ltd has said it has been imposed a penalty of over Rs 3 crore over GST-related issues. The company has received an order of...
Biocon registers consolidated revenue of Rs 4519 crore in Q3 Ruchika Sharma9 Feb 2024 4:03 PM ISTBengaluru: Bengaluru, Biocon Ltd, the Bengaluru-based pharmaceutical giant has announced its consolidated financial results for the fiscal third...
USFDA gives tentative nod to Biocon for cancer drug Dasatinib Ruchika Sharma7 Feb 2024 12:43 PM ISTBangalore: Biocon Limited has received tentative approval of its Abbreviated New Drug Application (ANDA) for Dasatinib tablets from the United...
Powered by innovative drugs, pharma industry can be worth USD 200 billion by 2030: Biocon Chief Ruchika Sharma25 Jan 2024 12:17 PM ISTMazumdar-Shaw also sought that the government ought to decouple private sector investment and ensure that academic research institutes are funded out...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
